Bristol-Myers Squibb vs Cisco: Founders, CEOs and History
Bristol-Myers Squibb was founded in 1887 by Edward Robinson Squibb, William McLaren Bristol, John Ripley Myers and is led by Christopher Boerner. Cisco was founded in 1984 by Leonard Bosack, Sandy Lerner and is led by Chuck Robbins.
Company facts
Bristol-Myers Squibb
- Founded
- 1887
- Headquarters
- Princeton, New Jersey
- Current CEO
- Christopher Boerner
- Employees
- 32,500
Cisco
- Founded
- 1984
- Headquarters
- San Jose, California
- Current CEO
- Chuck Robbins
- Employees
- 82,400
Founders
Bristol-Myers Squibb
Edward Robinson Squibb
Squibb resigned his Navy post and opened a small laboratory in Brooklyn in 1858 to make pure ether, chloroform and other medicines.
William McLaren Bristol
In 1887 Bristol and Myers bought the Clinton Pharmaceutical Company of Clinton, New York, reportedly for about $5,000.
John Ripley Myers
Myers and Bristol bought the Clinton Pharmaceutical Company in Clinton, New York, in 1887 and renamed it Bristol, Myers and Company in 1898.
Cisco
Leonard Bosack
Cisco Systems possesses one of the most famous, romanticized, and ultimately contentious founding stories in the history of Silicon Valley. The company was founded in 1984 by a husband-and-wife team, Leonard Bosack and Sandy Lerner.
Sandy Lerner
Sandy Lerner co-founded Cisco Systems in December 1984 with her then-husband Leonard Bosack, driven by the practical need to connect Stanford University's incompatible computer networks.
CEOs and their tenures
Bristol-Myers Squibb
- Charles A. Heimbold Jr.1994–2001
Chief Executive Officer
Serving as CEO from 1994 to 2001, he aggressively expanded the company's oncology portfolio, notably launching the blockbuster cancer drug Taxol, which drove massive revenue growth.
Source - Peter R. Dolan2001–2006
Chief Executive Officer
Dolan, who had run the consumer products and medical device divisions, succeeded Charles Heimbold in May 2001. His tenure included the ImClone partnership on the cancer drug Erbitux and a federal investigation into wholesaler inventory practices.
Source - James M. Cornelius2006–2010
Chief Executive Officer
Cornelius took over after Peter Dolan's removal in September 2006 and ran the company until May 2010.
Source - Lamberto Andreotti2010–2015
Chief Executive Officer
Andreotti, previously president and chief operating officer, became CEO on May 4, 2010.
Source - Giovanni Caforio2015–2023
Chief Executive Officer
Caforio, a physician, succeeded Lamberto Andreotti in May 2015. He led the $74 billion Celgene acquisition in 2019, the $13.1 billion MyoKardia deal in 2020 and the $4.1 billion Turning Point deal in 2022, and agreed the Mirati purchase in October 2023.
Source - Chris Boerner2023–present
Board Chair and Chief Executive Officer
Boerner became CEO in November 2023 and board chair on April 1, 2024, after serving as executive vice president, chief operating officer and CEO-designate from April 2023 and earlier as chief commercialization officer.
Source
Cisco
- John Morgridge1988–1995
Former CEO and Chairman
Morgridge was Cisco's first professional CEO, recruited in 1988 by Sequoia Capital investor Don Valentine to professionalize a company still run by its engineering founders.
Source - John Chambers1995–2015
Former Chairman and CEO
Chambers led Cisco for 20 years and transformed it through over 180 acquisitions into the dominant force in enterprise networking infrastructure.
Source - Chuck Robbins2015–present
Chairman and CEO
Robbins has led Cisco's fundamental shift from hardware networking products toward recurring software and subscription revenue. The 28 billion dollar Splunk acquisition in 2024 positioned Cisco as a leading security and observability platform vendor.
Source
Timeline: Bristol-Myers Squibb and Cisco side by side
1858Bristol-Myers Squibb
Edward Robinson Squibb opens his Brooklyn laboratory
Navy surgeon Edward Robinson Squibb started making pure ether and other medicines in Brooklyn. The laboratory burned down on Christmas Eve 1858 and reopened in 1859 after local doctors and surgeons contributed $2,100.
1887Bristol-Myers Squibb
Bristol and Myers buy the Clinton Pharmaceutical Company
Hamilton College graduates William McLaren Bristol and John Ripley Myers bought the Clinton Pharmaceutical Company of Clinton, New York, the business that became Bristol-Myers.
1898Bristol-Myers Squibb
Bristol, Myers and Company is named
The founders renamed the business Bristol, Myers and Company in May 1898. After Myers died in 1899 it became Bristol-Myers, which built national brands in Sal Hepatica and, from 1901, Ipana toothpaste.
1944Bristol-Myers Squibb
Penicillin at wartime scale
Squibb opened what was then the world's largest penicillin plant in New Brunswick, New Jersey. Bristol-Myers had bought Cheplin Biological Laboratories in East Syracuse, New York, in 1943 and converted it to penicillin for Allied forces.
1984Cisco
Company Founded at Stanford University
Leonard Bosack and Sandy Lerner incorporate Cisco Systems in December 1984, commercializing multi-protocol router technology developed to connect Stanford's campus networks.
1986Cisco
First Commercial Router Shipped
Cisco ships its first commercial multi-protocol router, the AGS (Advanced Gateway Server), generating $1.5 million in first-year revenue as the internet begins its transition from research network to commercial infrastructure.
1989Bristol-Myers Squibb
Bristol-Myers and Squibb merge
Bristol-Myers and Squibb combined to form Bristol-Myers Squibb, uniting a consumer and pharmaceutical company with a research-led drugmaker.
1990Cisco
Initial Public Offering on NASDAQ
Cisco goes public at a valuation of approximately $224 million, raising capital that would fuel its aggressive acquisition strategy. The IPO also precipitated the departure of both founders.
1995Cisco
John Chambers Becomes CEO
John Chambers takes over as CEO from John Morgridge, beginning a 20-year tenure that would see Cisco grow from $2 billion to over $47 billion in annual revenue through more than 180 acquisitions.
2000Cisco
Briefly Becomes World's Most Valuable Company
Cisco's market capitalization exceeds $500 billion in March 2000, briefly surpassing Microsoft and GE as the world's most valuable company before the dot-com crash erased over $400 billion in shareholder value.
2003Cisco
Acquisition of Linksys
Cisco acquires consumer networking company Linksys for $500 million, marking its entry into the home networking market and establishing a consumer brand that would later be divested to Belkin in 2013.
2006Bristol-Myers Squibb
CEO Peter Dolan removed over the Plavix deal
After an FBI raid in July 2006 over a patent settlement with generic maker Apotex on the blood thinner Plavix, the federal monitor urged the board to remove CEO Peter Dolan, who stepped down on September 12, 2006.
2009Bristol-Myers Squibb
Medarex bought and Mead Johnson split off
BMS bought Medarex, gaining Yervoy and a share of what became Opdivo, and split off Mead Johnson Nutrition in an exchange offer, completing its shift to a specialty biopharmaceutical company.
2011Bristol-Myers Squibb
FDA approves Yervoy
Yervoy (ipilimumab) became the first drug shown to extend overall survival in advanced melanoma, opening BMS's immuno-oncology franchise.
2012Bristol-Myers Squibb
FDA approves Eliquis
The FDA approved Eliquis (apixaban), developed with Pfizer, in December 2012 for stroke prevention in non-valvular atrial fibrillation. It became BMS's largest product, with $14.4 billion of sales in 2025.
2012Cisco
Meraki Acquisition Launches Cloud-Managed Networking
Cisco acquires cloud-managed networking startup Meraki for $1.2 billion, gaining the platform that would become central to its small-and-medium business strategy and its broader shift toward subscription-based management.
2014Bristol-Myers Squibb
FDA approves Opdivo
The FDA approved the PD-1 inhibitor Opdivo (nivolumab) in December 2014 for advanced melanoma. It reached $10.0 billion of sales in 2025.
2015Cisco
Chuck Robbins Appointed CEO
Chuck Robbins succeeds John Chambers as CEO, inheriting a mandate to transform Cisco from a hardware company into a software-and-subscription platform business capable of competing in the cloud era.
2017Cisco
AppDynamics Acquisition for $3.7 Billion
Cisco acquires application performance monitoring company AppDynamics for $3.7 billion just days before its planned IPO, signaling Cisco's strategic commitment to the observability and application intelligence market.
2019Bristol-Myers Squibb
Celgene acquisition closes
BMS completed its $74 billion purchase of Celgene on November 20, 2019, adding Revlimid, Pomalyst, Reblozyl and CAR-T programs. Celgene sold Otezla to Amgen for $13.4 billion to win regulatory approval.
2020Bristol-Myers Squibb
MyoKardia deal and a GAAP loss
BMS bought MyoKardia for $13.1 billion, gaining mavacamten (Camzyos). The deal's $11.4 billion in-process R&D charge pushed 2020 to a net loss despite $42.5 billion of revenue.
2020Cisco
Webex Usage Surges During COVID-19 Pandemic
Webex usage explodes to over 600 million meeting participants per month during the pandemic, temporarily positioning Cisco's collaboration platform as a critical piece of global remote work infrastructure.
2022Bristol-Myers Squibb
Turning Point bought as Revlimid generics arrive
BMS completed the $4.1 billion purchase of Turning Point Therapeutics in August 2022 while volume-limited generic lenalidomide began eroding Revlimid, which had peaked at $12.8 billion in 2021.
2023Bristol-Myers Squibb
Chris Boerner becomes CEO
Chris Boerner succeeded Giovanni Caforio as chief executive in November 2023 and became board chair on April 1, 2024. Weeks earlier BMS had agreed to buy Mirati, and in December it agreed to buy Karuna and RayzeBio.
2024Bristol-Myers Squibb
Karuna, Mirati and RayzeBio close; Cobenfy approved
The three deals closed between January and March 2024. On September 26, 2024 the FDA approved Cobenfy, the first schizophrenia drug that targets muscarinic rather than dopamine receptors. The Karuna charge produced an $8.9 billion net loss for 2024.
2024Cisco
$28 Billion Splunk Acquisition Completed
Cisco completes its largest-ever acquisition, purchasing cybersecurity and observability company Splunk for $28 billion in cash, pushing subscription revenue past 51% of total sales and establishing Cisco as a major force in security operations.
2025Bristol-Myers Squibb
BioNTech partnership, Orbital deal and $48.2B revenue
BMS agreed in June 2025 to co-develop BioNTech's bispecific BNT327 and in October 2025 to buy Orbital Therapeutics for $1.5 billion. Full-year revenue was $48.2 billion with the Growth Portfolio up 17 percent.
2025Cisco
AI Infrastructure Orders Exceed $2 Billion
Cisco's AI infrastructure orders from hyperscale customers surpass $2 billion in FY2025, more than doubling management's original target and validating the company's investment in Silicon One-based networking platforms for GPU cluster interconnection.
2026Bristol-Myers Squibb
Guidance raised and merger reports denied
On July 30, 2026 BMS raised its 2026 revenue guidance to $49.0 to $50.0 billion after second-quarter revenue of $12.97 billion. In August, reports of AstraZeneca merger talks were followed by a senior source telling Reuters there were no discussions.
Acquisitions
Bristol-Myers Squibb
- Orbital Therapeutics2025$1.5B
- Mirati Therapeutics2024$4.8B
- RayzeBio2024$4.1B
- Karuna Therapeutics2024$14B
- Turning Point Therapeutics2022$4.1B
- MyoKardia2020$13.1B
Questions about Bristol-Myers Squibb vs Cisco
Who is the CEO of Bristol-Myers Squibb Company and Cisco Systems, Inc.?
Bristol-Myers Squibb Company is led by Christopher Boerner and Cisco Systems, Inc. is led by Chuck Robbins. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bristol-Myers Squibb Company founded vs Cisco Systems, Inc.?
Bristol-Myers Squibb Company was founded in 1887 — 97 years before Cisco Systems, Inc., which was founded in 1984. Bristol-Myers Squibb Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Cisco Systems, Inc..
How many employees does Bristol-Myers Squibb Company have compared to Cisco Systems, Inc.?
Bristol-Myers Squibb Company employs approximately 32,500 people, while Cisco Systems, Inc. employs approximately 82,400. Cisco Systems, Inc. has the larger workforce at 82,400 employees, compared to Bristol-Myers Squibb Company's 32,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bristol-Myers Squibb Company and Cisco Systems, Inc. headquartered?
Both Bristol-Myers Squibb Company and Cisco Systems, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Bristol-Myers Squibb Company and Cisco Systems, Inc.?
Bristol-Myers Squibb Company was founded by Edward Robinson Squibb, William McLaren Bristol, John Ripley Myers. Cisco Systems, Inc. was founded by Leonard Bosack, Sandy Lerner.
Which company has a longer operating history — Bristol-Myers Squibb Company or Cisco Systems, Inc.?
Bristol-Myers Squibb Company has been operating for approximately 139 years, making it the more established of the two companies. Cisco Systems, Inc. has been in operation for around 42 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bristol-Myers Squibb vs Cisco overview